SCHEMBL18663265

SCHEMBL18663265

CCOC(=O)C1(C(=O)OCC)N=C(c2ccccc2)C=C1c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 2/20 0.40
ALOX15 P16050 1/20 0.40
ALOX5 P09917 1/20 0.39
OPRM1 P35372 4/20 0.39
TRPM8 Q7Z2W7 2/20 0.39
HPGDS O60760 1/20 0.39
OPRD1 P41143 2/20 0.38
OPRK1 P41145 2/20 0.38
ADORA3 P0DMS8 1/20 0.38
SLC22A1 O15245 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18663303 0.81 CACNA1D (0.39) SMN1; SMN2ALDH1A1GAAMAPTHPGD
SCHEMBL18663355 0.77 SLC6A4 (0.40) SMN1; SMN2ALDH1A1MAPTHPGDKDM4E
SCHEMBL18663299 0.72 MAPT (0.45) SMN1; SMN2ALDH1A1GAAMAPTHPGD
SCHEMBL18663251 0.72 CACNA1F (0.41) SMN1; SMN2ALDH1A1GAAMAPTHPGD
SCHEMBL19690491 0.71 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1GAAMAPTHPGD
SCHEMBL18663397 0.69 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1GAAMAPTHPGD
SCHEMBL9416753 0.68 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1GAAMAPTHPGD
SCHEMBL9049983 0.68 ATM (0.45) SMN1; SMN2ALDH1A1GAAMAPTHPGD
SCHEMBL9416757 0.67 GAA (0.44) SMN1; SMN2ALDH1A1GAAMAPTHPGD
SCHEMBL14657560 0.67 MAPT (0.44) SMN1; SMN2ALDH1A1GAAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF BEIJING LIHE TECH LTD (CN) 2017-03-30 US claimed
US-20190169328-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF RENQIU LIHE TECH LTD (CN) 2019-06-06 US disclosed
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF RENQIU LIHE TECH LTD (CN) 2017-12-14 US disclosed
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF BEIJING LIHE TECH LTD (CN) 2017-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF TEC, DGAT2, MOGAT2 SMN1; SMN2 4599/4885ALDH1A1 3281/4885GAA 3549/4885
US-20190169328-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF COG2, GTF2I, POF1B SMN1; SMN2 1503/4885ALDH1A1 2055/4885GAA 4791/4885
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF COG2, COG7, COG4 SMN1; SMN2 3127/4885ALDH1A1 2496/4885GAA 3658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.